Sort
172,184 grants matching “inflammation”
Improved bacterial strains for therapeutic DNA and protein production
$989,190Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2009 · GM
A preclinical multi-modal system for dynamic noninvasive assessment of liver disease
$989,080Tomasz Joseph Czernuszewicz · Sonovol, Inc. · SB1 · FY2021 · DK
Studies Of Central Nervous System Functional Anatomy
$988,963Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2010 · MH
Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial Intelligence
$988,957Piotr J Slomka · Cedars-Sinai Medical Center · R35 · FY2024 · HL
Novel immunotherapy against MOG antibody disease
$988,943Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2025 · TR
Biomarkers of Chronic Kidney Disease
$988,923Joseph Vincent Bonventre · Brigham And Women'S Hospital · U01 · FY2019 · DK
Development of a TRAIL-based therapy for alcohol related chronic pancreatitis
$988,751Victor V Roschke · Theraly Fibrosis, Inc. · U44 · FY2018 · AA
Macrophage Polarization in Response to Infections and Inflammation
$988,702Pradipta Ghosh · University Of California, San Diego · R01 · FY2021 · AI
Development of Synthetic High-Density Lipoproteins for Treatment of Sepsis
$988,469Elke Lipka · Tsrl, Inc. · R44 · FY2022 · GM
A 2D Intestinal Crypt Platform for Compound Screens
$988,431Bill Thelin · Altis Biosystems, Inc. · R44 · FY2022 · DK
InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation
$988,414Bill Thelin · Altis Biosystems, Inc. · R44 · FY2023 · TR
Molecular Prediction of Myeloma Initiation Molecular Prediction of Myeloma Initiation
$988,380Irene M. Ghobrial · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Opiate drug abuse and CNS vulnerability to HIV
$988,298Kurt Francis Hauser · University Of Kentucky · P01 · FY2006 · DA
AsthmaNet: Brigham and Women's Hospital & Children's Hospital Boston
$988,251Elliot Israel · Brigham And Women'S Hospital · U10 · FY2011 · HL
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung
$988,238Robert Tarran · Eldec Pharmaceuticals, Inc. · R42 · FY2022 · AI
Mechanisms in Blood Clotting
$988,138James H. Morrissey · University Of Michigan At Ann Arbor · R35 · FY2025 · HL
Mechanisms in Blood Clotting
$988,138James H. Morrissey · University Of Michigan At Ann Arbor · R35 · FY2024 · HL
Metabolomics of subclinical and clinical cardiovascular disease
$988,004Dean P. Jones · Emory University · P20 · FY2015 · HL
Genetic Susceptibility to Asthma and IndoorAir Pollution in Peru
$988,001Nadia N Hansel · Johns Hopkins University · R01 · FY2014 · ES
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent
$988,000Ke Zhang · Pacdna Llc · R42 · FY2024 · CA
Polymerase epsilon-based mouse and derived organoid models of intestinal cancer
$987,867Diego H Castrillon · Ut Southwestern Medical Center · R01 · FY2025 · CA
A systems immunology approach to evaluate malaria vaccine performance in endemic regions of Kenya
$987,659Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · U01 · FY2022 · AI
A systems immunology approach to evaluate malaria vaccine performance in endemic regions of Kenya
$987,659Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · U01 · FY2023 · AI
A systems immunology approach to evaluate malaria vaccine performance in endemic regions of Kenya
$987,656Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · U01 · FY2024 · AI
Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of
$987,616Stig K. Hansen · Carmot Therapeutics, Inc. · R44 · FY2013 · CA